The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0284
Bid: 0.03
Ask: 0.031
Change: 0.0029 (11.37%)
Spread: 0.001 (3.333%)
Open: 0.025
High: 0.04
Low: 0.025
Prev. Close: 0.0255
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conversion of Convertible Loan Notes

20 Dec 2021 07:00

RNS Number : 1677W
Supply @ME Capital PLC
20 December 2021
 

20 December 2021

Supply@ME Capital plc

(The "Company" or "SYME")

Conversion of Convertible Loan Notes

 

Supply@ME Capital plc, the innovative fintech platform (the "Platform") which provides the Inventory Monetisation© service to manufacturing and trading companies, announces that it has received a conversion notice from Mercator Capital Management Fund LP ("Mercator") in respect of £458,333.34 in principal amount of the Convertible Loan Notes issued by the Company on 1 December 2021, in lieu of a cash repayment, in accordance with the terms of the Loan Note Facility announced in the RNS of 29 September 2021. 

SYME issued Convertible Loan Notes with a total principal value of £458,333.34 on 1 December 2021, at its discretion, in order to support the working capital needs of the Company and its operating subsidiaries (the "Group").

Following receipt of the conversion notice, all £458,333.34 of the Convertible Loan Notes are to be converted into 381,340,661 Ordinary shares (the "Conversion Shares") at a conversion price of £0.0012. This represents 1.1% of the Company's issued share capital prior to the issue of the Conversion Shares. On conversion, no Convertible Loan Notes issued by the Company to Mercator on 1 December 2021, will remain outstanding.  In addition, as announced in the RNS dated 29 September 2021, warrants to Mercator have been issued for 20% of the total principal value of the Convertible Loan Notes and Loan Notes issued to date. 

Application has been made to the Financial Conduct Authority and to the London Stock Exchange for admission of the Conversion Shares to the standard segment of the Official List and to trading on the London Stock Exchange's main market for listed securities, respectively ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 21 December 2021. The Conversion Shares will rank pari passu with the existing issued Ordinary Shares in the Company. 

Notes

Supply@ME Capital PLC and its operating subsidiaries (together the "Group") provide an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/export transaction. SYME announced in August 2021 the launch of a global Inventory Monetisation program which will be focused on both inventory in transit monetisation and warehouse goods monetisation. This program will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories.

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com 

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317 brian.norris@cicero-group.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CONFIFFRFDLIFIL
Date   Source Headline
14th Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR
13th Sep 20227:00 amRNSHolding in Company
12th Sep 20227:00 amRNSInaugural IM transaction executed
6th Sep 20222:00 pmRNSPrice Monitoring Extension
5th Sep 202211:05 amRNSSecond Price Monitoring Extn
5th Sep 202211:00 amRNSPrice Monitoring Extension
5th Sep 20227:00 amRNSIssue of Equity & Total Voting Rights
31st Aug 20227:00 amRNSIssue of Equity & Total Voting Rights
30th Aug 20227:12 amRNSHolding in Company
23rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
23rd Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 20227:00 amRNSResult of Open Offer
17th Aug 202211:05 amRNSPDMR/PCA Shareholding: Stock Loans Updates
15th Aug 20224:41 pmRNSSecond Price Monitoring Extn
15th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20224:41 pmRNSSecond Price Monitoring Extn
10th Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20227:00 amRNSFirst IM Transaction: Binding commitment signed
8th Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20225:15 pmRNSTotal Voting Rights
1st Aug 20228:00 amRNSHolding in Company
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:36 pmRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSUpdate on first Inventory Monetisation Transaction
25th Jul 20227:00 amRNSDirectors/PDMR Shareholding
22nd Jul 20227:00 amRNSOpen Offer & Business Update
18th Jul 20221:13 pmRNSThird tranche of shares issued to Venus Capital
30th Jun 20224:29 pmRNSResult of AGM
28th Jun 20227:00 amRNSStrategic Alliance with VeChain Foundation
23rd Jun 20227:00 amRNSTradeflow and DP World complete first transaction
14th Jun 20227:00 amRNSNotice of AGM: CORRECTION
13th Jun 20227:00 amRNSAppointment of Independent Non-Executive Director
10th Jun 20227:00 amRNSNotice of AGM
6th Jun 20224:17 pmRNSPosting of 2021 Annual Report & Notice of AGM
6th Jun 20227:00 amRNSAppointment of new independent Non-Executive Chair
31st May 20227:00 amRNS2021 Annual Financial Report
25th May 20223:01 pmRNSTotal Voting Rights
10th May 20224:38 pmRNSSecond tranche of shares issued to Venus Capital
10th May 20227:00 amRNSSecond tranche of shares issued to Venus Capital
3rd May 20229:06 amRNSSecond Price Monitoring Extn
3rd May 20229:00 amRNSPrice Monitoring Extension
27th Apr 20222:06 pmRNSSecond Price Monitoring Extn
27th Apr 20222:00 pmRNSPrice Monitoring Extension
27th Apr 202211:05 amRNSSecond Price Monitoring Extn
27th Apr 202211:00 amRNSPrice Monitoring Extension
27th Apr 20229:05 amRNSSecond Price Monitoring Extn
27th Apr 20229:00 amRNSPrice Monitoring Extension
27th Apr 20227:01 amRNSCapital Enhancement Plan & Revised Date of Results
19th Apr 20227:00 amRNSBoard Change
12th Apr 20229:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.